Global Bioprocessing Systems Market Growth (Status and Outlook) 2023-2029
Manufacturing biologics is a complicated process and thus generally are outsourced by the manufacturers. Bioprocessing is the manufacturing process which helps in producing bio-based products such as vegetable oils, and fatty acids. The major applications of bioprocess industry are vaccines, tissue engineering, biosensors, and biopharmaceuticals. Bioprocessing also is known as biopharmaceutical manufacturing is a bioprocess used for the production of therapeutic cells.
LPI (LP Information)' newest research report, the “Bioprocessing Systems Industry Forecast” looks at past sales and reviews total world Bioprocessing Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Bioprocessing Systems sales for 2023 through 2029. With Bioprocessing Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioprocessing Systems industry.
This Insight Report provides a comprehensive analysis of the global Bioprocessing Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioprocessing Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioprocessing Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioprocessing Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioprocessing Systems.
The global Bioprocessing Systems market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The global bioprocessing systems market witnessed significant growth owing to increasing demand for bio-based products. The heavy demand for such systems by the industries such as food, pharmaceuticals, neutraceuticals, chemicals and polymers coupled with automation in the industrial process minimizing human errors have propelled the growth of global bioprocessing market. Moreover, the factors such as rising demand for biopharmaceutical production, increasing symptoms of chronic diseases, low manufacturing costs as compared to the artificial source of materials and improvisation of infrastructure in life science research has triggered the global bioprocessing systems during the forecast period 2017-2027. Growing demand for the single –use systems of the bioprocessing systems is expected to gain traction during the forecast period which is supposed to augment the global bioprocessing system market.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioprocessing Systems market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Upstream
Downstream
Single Use
Integrated
Segmentation by application
Vaccine Development
Cell Therapy and Plant Cell Cultivation
Filters
Tissue Engineering
Biosensors
Bioreactors and Mixers
Plasma Fractionation
Chromatography
Bio-therapeutic Molecule Production
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Pall Corporation
GE Healthcare
Nordson MEDICAL's
Thermo Fisher Scientific
EMD Millipore Corporation
PBS Biotech
Please note: The report will take approximately 2 business days to prepare and deliver.